These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6775393)

  • 21. Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits.
    Beach TG; Sue LI; Walker DG; Lue LF; Connor DJ; Caviness JN; Sabbagh MN; Adler CH
    Acta Neuropathol; 2007 Oct; 114(4):419-24. PubMed ID: 17639428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain.
    Zecca L; Pietra R; Goj C; Mecacci C; Radice D; Sabbioni E
    J Neurochem; 1994 Mar; 62(3):1097-101. PubMed ID: 8113797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased nigral neuromelanin in Alzheimer's disease.
    Reyes MG; Faraldi F; Rydman R; Wang CC
    Neurol Res; 2003 Mar; 25(2):179-82. PubMed ID: 12635519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
    Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB; Ben-Shachar D; Riederer P
    J Neural Transm Suppl; 1994; 43():113-22. PubMed ID: 7884393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical changes and manganese distribution in monkeys exposed to manganese dioxide dust.
    Nishiyama K; Suzuki Y; Fujii N; Yano H; Ohnishi K; Miyai T
    Tokushima J Exp Med; 1977 Dec; 24(3-4):137-45. PubMed ID: 418525
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipid content determines aggregation of neuromelanin granules in vitro.
    Dedov VN; Griffiths FM; Garner B; Halliday GM; Double KL
    J Neural Transm Suppl; 2007; (72):35-8. PubMed ID: 17982875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An ultrastructural study of lesions induced by sodium azide in the primate brain.
    Luse SA; Mettler FA; Blank W
    Trans Am Neurol Assoc; 1970; 95():57-8. PubMed ID: 4998769
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neuromelanin in neurons of substantia nigra lacking tyrosine hydroxylase].
    Grigor'ev IP; Sukhorukova EG; Kolos EA; Korzhevskiĭ DE
    Morfologiia; 2012; 141(2):65-7. PubMed ID: 22913142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.
    Faucheux BA; Martin ME; Beaumont C; Hauw JJ; Agid Y; Hirsch EC
    J Neurochem; 2003 Sep; 86(5):1142-8. PubMed ID: 12911622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
    D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH
    Nature; 1987 May 28-Jun 3; 327(6120):324-6. PubMed ID: 2884568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cysteinyldopamine is not incorporated into neuromelanin.
    Wakamatsu K; Ito S; Nagatsu T
    Neurosci Lett; 1991 Sep; 131(1):57-60. PubMed ID: 1791980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The histochemical distribution and localization of copper, iron, neuromelanin and lysosomal enzyme activity in the brain of aging rhesus monkey and the dog.
    Barden H
    J Neuropathol Exp Neurol; 1971 Oct; 30(4):650-67. PubMed ID: 5002647
    [No Abstract]   [Full Text] [Related]  

  • 34. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
    Zecca L; Berg D; Arzberger T; Ruprecht P; Rausch WD; Musicco M; Tampellini D; Riederer P; Gerlach M; Becker G
    Mov Disord; 2005 Oct; 20(10):1278-85. PubMed ID: 15986424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
    J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability of neuropathologic lesions in experimental methylmercurial encephalopathy in primates.
    Shaw CM; Mottet NK; Body RL; Luschei ES
    Am J Pathol; 1975 Sep; 80(3):451-70. PubMed ID: 821350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability.
    Gibb WR; Fearnley JM; Lees AJ
    Adv Neurol; 1990; 53():31-4. PubMed ID: 2173373
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuromelanin of the human substantia nigra: a mixed-type melanin.
    Odh G; Carstam R; Paulson J; Wittbjer A; Rosengren E; Rorsman H
    J Neurochem; 1994 May; 62(5):2030-6. PubMed ID: 8158151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive damage to substantia nigra in chronic alcoholics.
    Kariks J
    Med J Aust; 1978 Dec; 2(14):628-9. PubMed ID: 732673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation.
    Eriksson H; Mägiste K; Plantin LO; Fonnum F; Hedström KG; Theodorsson-Norheim E; Kristensson K; Stålberg E; Heilbronn E
    Arch Toxicol; 1987; 61(1):46-52. PubMed ID: 3439874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.